Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z0BQ
|
|||
| Drug Name |
US9650366, 9
|
|||
| Synonyms |
SCHEMBL17670002; OGVARLFWIBVKET-UHFFFAOYSA-N; BDBM308058; US9650366, 9; N-[3-({5-[2-(3-hydroxypropyl)-2H-tetrazol-5-yl]pyridin-3-yl}ethynyl)phenyl]-3-methyl-2-furamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H20N6O3
|
|||
| Canonical SMILES |
CC1=C(OC=C1)C(=O)NC2=CC=CC(=C2)C#CC3=CC(=CN=C3)C4=NN(N=N4)CCCO
|
|||
| InChI |
1S/C23H20N6O3/c1-16-8-11-32-21(16)23(31)25-20-5-2-4-17(13-20)6-7-18-12-19(15-24-14-18)22-26-28-29(27-22)9-3-10-30/h2,4-5,8,11-15,30H,3,9-10H2,1H3,(H,25,31)
|
|||
| InChIKey |
OGVARLFWIBVKET-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tyrosine-protein kinase EIF2AK2 (p68) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tyrosine-protein kinase EIF2AK2 (p68) | Target's Patent Info | [1] | |
| Panther Pathway | Apoptosis signaling pathway | |||
| Pathway Interaction Database | Signaling events mediated by TCPTP | |||
| Ceramide signaling pathway | ||||
| PDGFR-beta signaling pathway | ||||
| Reactome | ISG15 antiviral mechanism | |||
| WikiPathways | Type II interferon signaling (IFNG) | |||
| Host Interactions with Influenza Factors | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| Translation Factors | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors. US9650366. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.